FDA Ups Neuropathy Warning for Fluoroquinolones

Share this content:

The FDA is requiring the drug labels and Medication Guides for all fluoroquinolone antibacterial drugs be updated with the serious side effect of peripheral neuropathy. The nerve damage may occur soon after these drugs are taken by mouth or by injection, and may be permanent.

RELATED CHART: Antibiotic Formulations

The affected fluoroquinolone drugs include: Levaquin (levofloxacin; Janssen), Cipro (ciprofloxacin; Bayer), Avelox (moxifloxacin; Bayer), Noroxin (norfloxacin; Merck), Factive (gemifloxacin; Cornerstone), and Ofloxacin.

Topical formulations indicated for the ears or eyes are not known to be associated with this risk.

The FDA recommends discontinuing the fluoroquinolone if the patient develops symptoms of peripheral neuropathy. The patient should be switched to another, non-fluoroquinolone antibiotic unless the benefit outweighs the risk. Symptoms include pain, burning, tingling, numbness, weakness, or a change in sensation to light touch, pain or temperature, or the sense of body position.

For more information call (888) 463-6332 or visit FDA.gov

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs